Metronomic Oral Vinorelbine: An Alternative Schedule in Elderly and Patients PS2 With Local/Advanced and Metastatic NSCLC Not Oncogene-addicted

Conclusion: Our study confirmed the activity and safety of metronomic oral vinorelbine in patients with wild-type local/advanced and metastatic NSCLC unsuitable for treatment with standard i.v. chemotherapy, allowing patients a comfortable home-based therapy, thereby avoiding frequent hospital visits.

Source: In Vivo - August 30, 2020 Category: Research Authors: ROSSI, D., LIPPE, P., ROCCHI, M. B. L., SARTI, D., CATALANO, V., GRAZIANO, F., GIORDANI, P., BALDELLI, A., FEDELI, S. L., IMPERATORI, L., LAICI, G., CAPPELLETTI, C., TAMBURRANO, T., BRACCI, R., ALESSANDRONI, P. Tags: Clinical Studies Source Type: research